Adam Maeder
Stock Analyst at Piper Sandler
(3.92)
# 653
Out of 5,090 analysts
100
Total ratings
54.55%
Success rate
10.36%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $12 → $9 | $4.89 | +84.05% | 9 | Nov 14, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $4 → $5 | $8.05 | -37.89% | 2 | Nov 7, 2025 | |
| TCMD Tactile Systems Technology | Reiterates: Neutral | $14 → $20 | $27.91 | -28.34% | 4 | Nov 4, 2025 | |
| INSP Inspire Medical Systems | Reiterates: Overweight | $150 → $135 | $136.81 | -1.32% | 16 | Nov 4, 2025 | |
| EW Edwards Lifesciences | Reiterates: Overweight | $90 → $95 | $86.19 | +10.22% | 17 | Oct 31, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Overweight | $595 → $610 | $575.34 | +6.02% | 21 | Oct 22, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $8.5 → $7 | $2.98 | +134.90% | 8 | Aug 13, 2025 | |
| RMD ResMed | Maintains: Neutral | $248 → $270 | $256.55 | +5.24% | 4 | Aug 1, 2025 | |
| RXST RxSight | Maintains: Neutral | $18 → $10 | $12.63 | -20.82% | 2 | Jul 9, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $1.88 | +112.77% | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $133 → $145 | $125.08 | +15.93% | 3 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $22.85 | -8.10% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $1.35 | +492.59% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.41 | +107.47% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $0.89 | +1,922.47% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $63.36 | +56.25% | 3 | May 5, 2022 |
Nyxoah
Nov 14, 2025
Reiterates: Overweight
Price Target: $12 → $9
Current: $4.89
Upside: +84.05%
Sight Sciences
Nov 7, 2025
Maintains: Neutral
Price Target: $4 → $5
Current: $8.05
Upside: -37.89%
Tactile Systems Technology
Nov 4, 2025
Reiterates: Neutral
Price Target: $14 → $20
Current: $27.91
Upside: -28.34%
Inspire Medical Systems
Nov 4, 2025
Reiterates: Overweight
Price Target: $150 → $135
Current: $136.81
Upside: -1.32%
Edwards Lifesciences
Oct 31, 2025
Reiterates: Overweight
Price Target: $90 → $95
Current: $86.19
Upside: +10.22%
Intuitive Surgical
Oct 22, 2025
Reiterates: Overweight
Price Target: $595 → $610
Current: $575.34
Upside: +6.02%
Vicarious Surgical
Aug 13, 2025
Maintains: Neutral
Price Target: $8.5 → $7
Current: $2.98
Upside: +134.90%
ResMed
Aug 1, 2025
Maintains: Neutral
Price Target: $248 → $270
Current: $256.55
Upside: +5.24%
RxSight
Jul 9, 2025
Maintains: Neutral
Price Target: $18 → $10
Current: $12.63
Upside: -20.82%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $1.88
Upside: +112.77%
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $125.08
Upside: +15.93%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $22.85
Upside: -8.10%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $1.35
Upside: +492.59%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.41
Upside: +107.47%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $0.89
Upside: +1,922.47%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $63.36
Upside: +56.25%